Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.

Literature DB >> 4881420

Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.

P B Doak, J Z Montgomerie, J D North, F Smith.

Abstract

Two patients developed reticulum cell sarcomata after they had been treated with azathioprine and prednisone in the course of cadaveric renal transplantation. Both had terminal widespread herpes simplex virus infection.Immunosuppressive therapy could be responsible for an increased risk of malignant lymphomata either directly or by facilitating infection with oncogenic viruses.

Entities: Chemical Disease Species

Mesh：

Substances：
Azathioprine
Prednisone

Year: 1968 PMID： 4881420 PMCID： PMC1912885 DOI： 10.1136/bmj.4.5633.746

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

15 in total

1. Autoimmune reactions and virus-like particles in germ-free NZB mice.

Authors: J East; P R Prosser; E J Holborow; H Jaquet
Journal: Lancet Date: 1967-04-08 Impact factor: 79.321

2. Immunological aspects of malignant disease.

Authors: F M Burnet
Journal: Lancet Date: 1967-06-03 Impact factor: 79.321

3. Effects of antilymphocyte serum on virus oncogenesis.

Authors: A C Allison; L W Law
Journal: Proc Soc Exp Biol Med Date: 1968-01

4. Agent of Marek's disease in tissue culture.

Authors: A E Churchill; P M Biggs
Journal: Nature Date: 1967-07-29 Impact factor: 49.962

5. Survival of skin heterografts under treatment with antilymphocytic serum.

Authors: E M Lance; P B Medawar
Journal: Lancet Date: 1968-06-01 Impact factor: 79.321

6. Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation.

Authors: T E Starzl; C G Groth; P I Terasaki; C W Putnam; L Brettschneider; T L Marchioro
Journal: Surg Gynecol Obstet Date: 1968-05

7. Immunosuppression in allogeneic murine tumour system. A model for the study of antilymphocyte serum.

Authors: S D Deodhar; G Crile; P F Schofield
Journal: Lancet Date: 1968-01-27 Impact factor: 79.321

8. Immunologic rejection of human cancer transplanted with a renal allograft.

Authors: R E Wilson; E B Hager; C L Hampers; J M Corson; J P Merrill; J E Murray
Journal: N Engl J Med Date: 1968-02-29 Impact factor: 91.245

9. Immune reactivity prior to development of thymic lymphoma in C57BL mice.

Authors: R G Doell; C De Vaux St Cyr; P Grabar
Journal: Int J Cancer Date: 1967-03-15 Impact factor: 7.396

10. Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder.

Authors: R S Schwartz; L Beldotti
Journal: Science Date: 1965-09-24 Impact factor: 47.728

44 in total

1. Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience.

Authors: Chikashi Nakanishi; Naoki Kawagishi; Satoshi Sekiguchi; Yorihiro Akamatsu; Kazushige Sato; Shigehito Miyagi; Ikuo Takeda; Daizo Fukushima; Yoshinobu Kobayashi; Kazuyuki Ishida; Hidetaka Niizuma; Shigeru Tsuchiya; Motoshi Wada; Masaki Nio; Susumu Satomi
Journal: Surg Today Date: 2012-01-26 Impact factor: 2.549

Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.

1. Autoimmune reactions and virus-like particles in germ-free NZB mice.

2. Immunological aspects of malignant disease.

3. Effects of antilymphocyte serum on virus oncogenesis.

4. Agent of Marek's disease in tissue culture.

5. Survival of skin heterografts under treatment with antilymphocytic serum.

6. Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation.

7. Immunosuppression in allogeneic murine tumour system. A model for the study of antilymphocyte serum.

8. Immunologic rejection of human cancer transplanted with a renal allograft.

9. Immune reactivity prior to development of thymic lymphoma in C57BL mice.

10. Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder.

1. Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience.

Review 2. Post Transplant Lymphoproliferative Disorder.

Review 3. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Review 4. Antineoplastic and immunosuppressive drugs. 3. Adverse effects and therapeutic problems.

5. Cancer research: preparing for a long haul.

6. Tumour development following immunosuppression.

Review 7. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.

8. Intestinal lymphoma with unusual sequence of serum IgA changes.

9. Multiple myeloma: development of plasma cell sarcoma during apparently successful chemotherapy.

10. Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisolone and azathioprine.